These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8088310

  • 1. Effects of insulin-like growth factor-I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs.
    Umpleby AM, Shojaee-Moradie F, Thomason MJ, Kelly JM, Skottner A, Sonksen PH, Jones RH.
    Eur J Clin Invest; 1994 May; 24(5):337-44. PubMed ID: 8088310
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the effects of insulin-like growth factor-I, insulin and combined infusions of insulin and insulin-like growth factor-I on glucose metabolism in dogs.
    Shojaee-Moradie F, Umpleby AM, Thomason MJ, Jackson NC, Boroujerdi MA, Sönksen PH, Skottner A, Jones RH.
    Eur J Clin Invest; 1995 Dec; 25(12):920-8. PubMed ID: 8719932
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
    Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP, Minaker KL, Miles JM, Rubenstein AH, Vandepol CJ.
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R, Ninnis R, Keller U.
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [Abstract] [Full Text] [Related]

  • 5. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.
    Turkalj I, Keller U, Ninnis R, Vosmeer S, Stauffacher W.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1186-91. PubMed ID: 1430077
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of human recombinant insulin-like growth factor I and insulin on plasma amino acid concentrations and leucine kinetics in humans.
    Giordano M, Castellino P, Carroll CA, DeFronzo RA.
    Diabetologia; 1995 Jun; 38(6):732-8. PubMed ID: 7672498
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factor-I and insulin reduce leucine flux and oxidation in conscious tumor necrosis factor-infused dogs.
    Sakurai Y, Zhang XJ, Wolfe RR.
    Surgery; 1995 Mar; 117(3):305-13. PubMed ID: 7878537
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs.
    Koea JB, Douglas RG, Breier BH, Shaw JH, Gluckman PD.
    Endocrinology; 1992 Aug; 131(2):643-8. PubMed ID: 1639012
    [Abstract] [Full Text] [Related]

  • 9. Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans.
    Russell-Jones DL, Umpleby AM, Hennessy TR, Bowes SB, Shojaee-Moradie F, Hopkins KD, Jackson NC, Kelly JM, Jones RH, Sönksen PH.
    Am J Physiol; 1994 Oct; 267(4 Pt 1):E591-8. PubMed ID: 7943309
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.
    Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS.
    J Clin Invest; 1989 May; 83(5):1717-23. PubMed ID: 2651479
    [Abstract] [Full Text] [Related]

  • 11. Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women.
    Braun B, Friedlander AL, Pollack M, Butterfield GE, Marcus R, Hoffman AR.
    Metabolism; 2003 Sep; 52(9):1182-90. PubMed ID: 14506625
    [Abstract] [Full Text] [Related]

  • 12. The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp.
    Russell-Jones DL, Umpleby AM, Shojaee-Moradie F, Boroujerdi MA, Jones RH, Baxter RC, Sönksen PH.
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):685-91. PubMed ID: 9497875
    [Abstract] [Full Text] [Related]

  • 13. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [Abstract] [Full Text] [Related]

  • 14. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
    Douglas RG, Gluckman PD, Ball K, Breier B, Shaw JH.
    J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
    [Abstract] [Full Text] [Related]

  • 15. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
    Berneis K, Ninnis R, Girard J, Frey BM, Keller U.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of IGF-I and insulin on glucoregulation and fat metabolism in depancreatized dogs.
    Giacca A, Gupta R, Efendic S, Hall K, Skottner A, Lickley L, Vranic M.
    Diabetes; 1990 Mar; 39(3):340-7. PubMed ID: 2407583
    [Abstract] [Full Text] [Related]

  • 17. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [Abstract] [Full Text] [Related]

  • 18. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N, Horber FF, Haymond MW.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [Abstract] [Full Text] [Related]

  • 19. Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs.
    Fisher SJ, Shi ZQ, Lickley HL, Efendic S, Vranic M, Giacca A.
    J Endocrinol; 2001 Jan; 168(1):49-58. PubMed ID: 11139769
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-I and insulin have no differential effects on glucose production and utilization under conditions of hyperglycemia.
    Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Skottner A, Anderson GH, Efendic S, Vranic M.
    Endocrinology; 1994 May; 134(5):2251-8. PubMed ID: 8156929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.